pmc logo image
Logo of amjpatholAmerican Journal of Pathology For AuthorsAmerican Journal of Pathology SubscribeAmerican Journal of Pathology SearchAmerican Journal of Pathology Current IssueAmerican Journal of Pathology About the JournalAmerican Journal of Pathology

Formats:

Am J Pathol. 1989 March; 134(3): 641–649.
PMCID: PMC1879514
Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
H. J. Kahn, H. Yeger, R. Loftus, and M. H. Goldrosen
Department of Pathology, Women's College Hospital, Toronto, Ontario, Canada.
Abstract
A monoclonal antibody designated RWP1.1 was produced against a human pancreatic carcinoma cell line RWP1. This antibody was shown to recognize an epitope of carcinoembryonic antigen. The reactivity of the antibody was evaluated on formalin-fixed normal tissues, 86 malignant neoplasms, 10 colonic polyps, and 6 cases of chronic pancreatitis using the peroxidase anti-peroxidase technique. RWP1.1 did not react with normal tissues apart from weak staining of fetal pancreatic ducts. This antibody preferentially reacted with primary and metastatic adenocarcinomas of the colon, stomach, pancreas, and colonic polyps but not with most adenocarcinomas from other sites nor with other types of tumors or cases of chronic pancreatitis. It also reacted with colon adenocarcinomas on frozen sections. The restricted specificity of this antibody could be used in differentiating gastrointestinal adenocarcinomas from other types of tumors including adenocarcinomas from other sites and most pancreatic adenocarcinomas from chronic pancreatitis.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer. 1975 May 15;15(5):741–747. [PubMed]
  • Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer. 1977 Jan;19(1):128–135. [PubMed]
  • Akagi T, Kimoto T. Establishment and characteristics of a human pancreatic cancer cell line (HCG-25). Acta Pathol Jpn. 1977 Jan;27(1):51–58. [PubMed]
  • Dexter DL, Matook GM, Meitner PA, Bogaars HA, Jolly GA, Turner MD, Calabresi P. Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice. Cancer Res. 1982 Jul;42(7):2705–2714. [PubMed]
  • Chin J, Zuna R, Miller F. Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin. Am J Pathol. 1987 Jan;126(1):183–193. [PubMed]
  • Kaku M, Nishiyama T, Yagawa K, Abe M. Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. Gann. 1980 Oct;71(5):596–601. [PubMed]
  • Iwamura T, Katsuki T, Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res. 1987 Jan;78(1):54–62. [PubMed]
  • GOLD P, FREEDMAN SO. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. [PubMed]
  • von Kleist S, Chavanel G, Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. [PubMed]
  • Burtin P, Chavanel G, Hirsch-Marie H. Characterization of a second normal antigen that cross-reacts with CEA. J Immunol. 1973 Dec;111(6):1926–1928. [PubMed]
  • Tsutsumi Y, Nagura H, Watanabe K. Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas. Pitfalls and caveats in CEA immunohistochemistry. Am J Clin Pathol. 1984 Nov;82(5):535–542. [PubMed]
  • Matsuoka Y, Koga Y, Maruta H, Yoshino M, Tsuru E. Proteolytic release of antigenic fragments corresponding to normal fecal antigen and non-specific cross-reacting antigen from carcinoembryonic antigen. Int J Cancer. 1978 May 15;21(5):604–610. [PubMed]
  • Matsuoka Y, Kuroki M, Koga Y, Kuriyama H, Mori T, Kosaki G. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces. Cancer Res. 1982 May;42(5):2012–2018. [PubMed]
  • Kuroki M, Koga Y, Matsuoka Y. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces. Cancer Res. 1981 Feb;41(2):713–720. [PubMed]
  • Svenberg T. Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization. Int J Cancer. 1976 May 15;17(5):588–596. [PubMed]
  • Muraro R, Wunderlich D, Thor A, Lundy J, Noguchi P, Cunningham R, Schlom J. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 1985 Nov;45(11 Pt 2):5769–5780. [PubMed]
  • Thor A, Muraro R, Gorstein F, Ohuchi N, Viglione M, Szpak CA, Johnston WW, Schlom J. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity. Cancer Res. 1987 Jan 15;47(2):505–512. [PubMed]
  • Shulman M, Wilde CD, Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 1978 Nov 16;276(5685):269–270. [PubMed]
  • Toth CA, Thomas P, Broitman SA, Zamcheck N. Receptor-mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells. Cancer Res. 1985 Jan;45(1):392–397. [PubMed]
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. [PubMed]
  • Grant AG, Duke D, Hermon-Taylor J. Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice. Br J Cancer. 1979 Feb;39(2):143–151. [PubMed]
  • Imai K, Moriya Y, Fujita H, Tsujisaki M, Kawaharada M, Yachi A. Immunologic characterization and molecular profile of carcinoembryonic antigen detected by monoclonal antibodies. J Immunol. 1984 Jun;132(6):2992–2997. [PubMed]
  • Bosslet K, Lüben G, Schwarz A, Hundt E, Harthus HP, Seiler FR, Muhrer C, Klöppel G, Kayser K, Sedlacek HH. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer. 1985 Jul 15;36(1):75–84. [PubMed]
  • Nuti M, Teramoto YA, Mariani-Costantini R, Hand PH, Colcher D, Schlom J. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer. 1982 May 15;29(5):539–545. [PubMed]
  • Allum WH, Stokes HJ, Macdonald F, Fielding JW. Demonstration of carcinoembryonic antigen (CEA) expression in normal, chronically inflamed, and malignant pancreatic tissue by immunohistochemistry. J Clin Pathol. 1986 Jun;39(6):610–614. [PubMed]
  • Wahren B, Hammarström S, Harmenberg U, von Krusenstierna S, Larsson SA, Lundell G, Rudén U, Schnell PO. Polyclonal and monoclonal anti-CEA antibodies in immunolocalization of colorectal cancer. Tumour Biol. 1986;7(5-6):361–369. [PubMed]
  • Klug TL, Sattler MA, Colcher D, Schlom J. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int J Cancer. 1986 Nov 15;38(5):661–669. [PubMed]
  • Tatsuta M, Yamamura H, Iishi H, Ichii M, Noguchi S, Yamamoto R, Okuda S. Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer. 1985 Dec 1;56(11):2669–2673. [PubMed]
  • Sawabu N, Toya D, Takemori Y, Hattori N, Fukui M. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. Int J Cancer. 1986 May 15;37(5):693–696. [PubMed]